Expert Weight Loss Clinics That Prescribe Mounjaro

By Dr. Crystal Broussard, MD — Board-Certified Family Medicine Physician, Fellow of the American Board of Obesity Medicine, Physician-Owner and Medical Director of Harmony Aesthetics Spa

Last medically reviewed and updated: February 2026

Introduction

As a board-certified family physician and Fellow of the American Board of Obesity Medicine with over 20 years of clinical experience, I understand how deeply weight challenges affect not just your body, but your confidence, your energy, and your hope.

Weight loss clinics that prescribe Mounjaro are physician-led medical practices where a board-certified doctor evaluates your health comprehensively and builds a treatment plan around tirzepatide — the dual-action medication that has become a breakthrough in obesity medicine. Here at our clinic in Spring, TX, serving North Houston, The Woodlands, Kingwood, and Tomball, I’ve seen how addressing the whole person — metabolism, hormones, lifestyle, emotional health — leads to real, lasting change.

For many of my patients, especially women navigating midlife transitions, hormonal shifts, thyroid dysfunction, PCOS, and years of disappointment with generic programs make weight loss feel impossible. The newest research validates what I see daily in clinical practice: physician-guided tirzepatide programs produce significantly greater results than unsupervised or online-only approaches.

If you’re tired of being dismissed or stuck with one-size-fits-all solutions, you deserve an approach that’s personal, physician-led, and focused on your whole well-being. That’s exactly what I built my practice to provide.

What Is Mounjaro (Tirzepatide) and How Does It Work?

Mounjaro is the brand name for tirzepatide, a prescription medication classified as a dual GIP/GLP-1 receptor agonist. Unlike older GLP-1-only medications (such as semaglutide, the active ingredient in Ozempic and Wegovy), tirzepatide uniquely targets two incretin hormones simultaneously:

GLP-1 (glucagon-like peptide-1): Helps regulate blood sugar, slows gastric emptying so you feel full longer, and acts on brain receptors that control appetite.

GIP (glucose-dependent insulinotropic polypeptide): Enhances the metabolic effects of GLP-1, supports insulin sensitivity, and contributes to greater overall weight reduction than GLP-1-only medications.

This dual mechanism is what makes tirzepatide different from every other weight loss medication on the market today. It’s not just suppressing appetite — it’s addressing multiple metabolic pathways that drive weight gain and make weight loss resistant.

What I See in Clinical Practice

In my experience treating hundreds of patients with tirzepatide-based programs, women entering perimenopause or dealing with thyroid challenges often face unique metabolic hurdles that single-pathway medications can’t fully address. The dual-hormone action of tirzepatide supports broader metabolic balance — helping patients break through plateaus that have frustrated them for years.

I’ve watched patients who had lost hope finally achieve transformative results. Not just numbers on a scale, but improvements in energy, sleep quality, joint pain, blood pressure, and the confidence to feel like themselves again.

Mounjaro vs. Zepbound: Understanding the Difference

This is a question I get frequently at our Spring, TX clinic: “What’s the difference between Mounjaro and Zepbound?”

Both medications contain the exact same active ingredient — tirzepatide — manufactured by Eli Lilly. The difference is in their FDA-approved indications:

Feature	Mounjaro	Zepbound
Active Ingredient	Tirzepatide	Tirzepatide
FDA Approval	Type 2 diabetes (May 2022)	Chronic weight management (Nov 2023)
Eligible Patients	Adults with type 2 diabetes	Adults with BMI ≥30, or BMI ≥27 with a weight-related condition
Mechanism	Dual GIP/GLP-1 agonist	Dual GIP/GLP-1 agonist
Administration	Once-weekly subcutaneous injection	Once-weekly subcutaneous injection
Available Doses	2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg	2.5 mg, 5 mg, 10 mg, 15 mg

During your consultation, I’ll determine which prescription pathway is most appropriate based on your medical history, insurance coverage, and health goals.

Research-Backed Results: What the Latest Clinical Evidence Shows

One of the things that sets a physician-led weight loss clinic apart is our ability to interpret and apply clinical research to your individual care. Here’s what the most current evidence tells us about tirzepatide:

SURMOUNT-1: The Landmark Obesity Trial

The original SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled over 2,500 adults with obesity or overweight (without diabetes). Over 72 weeks, participants achieved remarkable results:

• 5 mg dose: Average weight loss of 15.0%
• 10 mg dose: Average weight loss of 19.5%
• 15 mg dose: Average weight loss of 20.9%
• Placebo: Average weight loss of 3.1%

More than 90% of participants on the highest dose achieved at least 5% weight loss, and over 56% lost at least 20% of their body weight.

Three-Year Data: Weight Loss That Lasts

The three-year extension of SURMOUNT-1 (176 weeks) — the longest completed tirzepatide study — was published in the NEJM and presented at ObesityWeek 2024. Key findings:

• Patients on the 15 mg dose sustained an average weight loss of 22.9% over three full years.
• Nearly 99% of participants with pre-diabetes remained diabetes-free through the study period.
• This addresses one of the biggest concerns my patients have: “Will I just gain it all back?” The evidence says sustained results are achievable with ongoing treatment and lifestyle modification.

SURMOUNT-5: Tirzepatide Beats Semaglutide Head-to-Head

Published in May 2025 in the New England Journal of Medicine, the SURMOUNT-5 trial was the first direct head-to-head comparison of tirzepatide versus semaglutide in adults with obesity (without diabetes):

• Tirzepatide: Average weight loss of 20.2%
• Semaglutide: Average weight loss of 13.7%
• Tirzepatide was statistically superior for both total weight loss and waist circumference reduction.

This is an important data point for patients who ask me whether Mounjaro/Zepbound is truly different from Ozempic/Wegovy. The clinical evidence now clearly demonstrates tirzepatide’s advantage.

SURMOUNT-3: After Lifestyle Changes

In the SURMOUNT-3 trial, patients who had already lost 5% of their weight through lifestyle changes alone were then randomized to tirzepatide or placebo. Those on tirzepatide achieved an additional 18.4% weight reduction — compared to just 2.5% with placebo. Nearly one-third lost 25% or more of their total body weight.

Cardiovascular Safety: SURPASS-CVOT

Published in the New England Journal of Medicine in December 2025, the SURPASS-CVOT trial (over 4 years of follow-up) confirmed that tirzepatide is safe for cardiovascular outcomes and showed favorable trends compared to dulaglutide in patients with type 2 diabetes and established heart disease. Patients on tirzepatide also experienced greater reductions in body weight (-11.6% vs. -4.5%) and hemoglobin A1c.

From My Perspective as an Obesity Medicine Physician

The real value of these studies isn’t just the numbers — it’s how they translate to your daily life. I’ve watched patients who previously lost hope finally achieve double-digit weight loss and report dramatic improvements in energy, mobility, sleep, and self-esteem. When combined with a personalized lifestyle plan, nutrition guidance, and ongoing medical oversight, these outcomes become sustainable over the long term.

Who Is Eligible for Mounjaro or Tirzepatide?

Based on current FDA guidelines and clinical research, you may be a candidate for tirzepatide treatment if you meet the following criteria:

For Zepbound (weight management indication):

• BMI of 30 or higher (classified as obesity), OR
• BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, prediabetes, type 2 diabetes, high cholesterol, obstructive sleep apnea, or cardiovascular disease

For Mounjaro (type 2 diabetes indication):

• Diagnosis of type 2 diabetes, used alongside diet and exercise to improve blood sugar control

Who should NOT take tirzepatide:

• Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
• Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Anyone with a known hypersensitivity to tirzepatide
• Currently pregnant or breastfeeding individuals (discuss family planning with your physician)

I always start with a thorough evaluation — including lab work, metabolic health screening, and a detailed health history — to make sure tirzepatide is the right fit for your specific situation. This personalized approach is key to both safety and long-term success, especially when considering the underlying causes of weight gain that may be present.

Mounjaro vs. Ozempic vs. Wegovy: How Do They Compare?

One of the most common questions I hear from patients at our Spring, TX clinic is how these medications stack up against each other. Here’s an evidence-based comparison:

Feature	Mounjaro / Zepbound (Tirzepatide)	Ozempic / Wegovy (Semaglutide)
Drug Class	Dual GIP/GLP-1 receptor agonist	GLP-1 receptor agonist only
Average Weight Loss (72 wks)	15–22.9% (dose-dependent)	12–16.9% (dose-dependent)
Head-to-Head Winner (SURMOUNT-5)	✓ Superior (20.2% average)	13.7% average
3-Year Sustained Data	22.9% sustained (SURMOUNT-1 extension)	Data available for semaglutide as well
FDA Approvals	Type 2 diabetes (Mounjaro), Weight management (Zepbound)	Type 2 diabetes (Ozempic), Weight management (Wegovy)
Administration	Once-weekly subcutaneous injection	Once-weekly subcutaneous injection
Cardiovascular Outcomes Data	SURPASS-CVOT (noninferior to dulaglutide)	SELECT trial (reduced MACE events)
Common Side Effects	Nausea, diarrhea, decreased appetite, vomiting, constipation	Nausea, diarrhea, vomiting, constipation, abdominal pain

Both medication classes are effective. The choice between them depends on your medical history, insurance coverage, individual response, and treatment goals — which is exactly why physician oversight matters so much.

In my clinical experience, patients who haven’t responded optimally to semaglutide often see significant improvement when switched to tirzepatide, likely due to the additional GIP pathway activation.

Why Physician-Led Supervision Matters for GLP-1 Medications

Choosing a physician-led clinic for GLP-1 weight loss medications like Mounjaro is about far more than getting a prescription filled. It’s about safety, results, and having a medical partner who truly understands the complexity of obesity as a chronic disease.

The Risks of Unsupervised or Online-Only Programs

Not all clinics or telehealth services provide the same level of care. Without proper medical supervision, patients risk:

• Unsafe dosing without baseline lab work or health screening
• Missed diagnoses — thyroid dysfunction, PCOS, insulin resistance, sleep apnea, and hormonal imbalances can all drive weight gain and require specific treatment
• Unmanaged side effects that could be addressed with simple protocol adjustments
• Drug interactions that aren’t caught without a complete medication review
• No accountability or follow-up — which research consistently links to lower success rates

I’ve treated patients who came to our Spring, TX clinic after trying unsupervised programs, frustrated by poor results or complications that could have been prevented. That experience reinforced my commitment to a comprehensive, safety-first approach.

Integrated Obesity, Hormone, and Metabolic Management

Weight loss isn’t simply about calories in and out. In my practice, I see the profound impact that hormones, stress, sleep, and life transitions have on a patient’s ability to lose weight and keep it off. That’s why I combine GLP-1 therapy with:

• Hormone optimization — addressing estrogen, progesterone, testosterone, and thyroid imbalances that commonly derail weight loss, especially during perimenopause and menopause
• Insulin resistance evaluation and management — a root metabolic cause of weight gain that many programs overlook entirely
• Comprehensive lab work — including metabolic panels, thyroid function, A1c, lipids, and hormone levels
• Body composition analysis — tracking fat loss vs. muscle preservation, not just scale weight
• Nutrition and lifestyle coaching — sustainable behavioral changes that support long-term results
• IV nutrient therapy — supporting energy, recovery, and micronutrient status during active weight loss

This integrated approach addresses root causes rather than just symptoms, leading to fewer setbacks and improved overall well-being. You deserve a plan that sees the whole you — not just your weight.

Why Choose Harmony Aesthetics Spa for Mounjaro in Spring, TX?

At Harmony Aesthetics Spa, you’re cared for by a board-certified physician with specialized training in obesity medicine — not a nurse practitioner working remotely, not an algorithm generating prescriptions.

Dr. Broussard’s Credentials

I’m a board-certified family physician and Fellow of the American Board of Obesity Medicine. This means I understand the complex, interconnected factors behind weight gain — from hormones to genetics to lifestyle to emotional health. I’ve helped hundreds of patients across the Spring, TX and North Houston area achieve meaningful, lasting results after years of frustration with other programs.

Personal Success Meets Medical Expertise

Having lost 100 pounds myself, I know firsthand how overwhelming and isolating weight struggles can feel. That lived experience, combined with two decades of medical practice, drives everything about how I designed our program. You’re never treated as “just a number” — every patient receives individualized attention, compassion, and evidence-based care.

A Full Spectrum of Services Under One Roof

Unlike online-only or aesthetics-focused clinics, we offer comprehensive care across your entire health and confidence journey:

• Medical weight loss with GLP-1 therapy — Mounjaro, Zepbound, semaglutide, and other options
• Hormone balance and optimization — addressing the metabolic factors that drive weight gain
• Body contouring — non-surgical treatments to address stubborn areas and skin laxity during or after weight loss
• Skin rejuvenation and facial treatments — because confidence encompasses how you feel in your skin
• Laser services — including treatments for acne scarring, sun damage, and skin texture
• Sexual wellness — addressing intimacy concerns that often accompany hormonal changes and weight fluctuations

Our Proven Program: What to Expect at Your Mounjaro Weight Loss Clinic Visit

When you join our program, you receive far more than a prescription — you get a personalized, physician-led wellness plan designed for lasting transformation.

Step 1: Comprehensive Initial Consultation

Your journey begins with a thorough evaluation. During this visit, I personally:

• Review your complete health history, current medications, and any previous weight loss attempts
• Order and evaluate comprehensive lab work (metabolic panel, thyroid function, A1c, lipids, hormone levels)
• Perform a body composition analysis to establish your baseline
• Discuss your goals, lifestyle, and any past challenges with weight management
• Evaluate for underlying conditions — including insulin resistance, thyroid disorders, PCOS, and hormonal imbalances — that may be contributing to weight gain
• Determine whether Mounjaro (tirzepatide), semaglutide, or another approach is the safest and most effective choice for your specific needs

Based on treating hundreds of patients, I’ve found that this depth of evaluation is exactly what’s missing from most other programs. By identifying contributors like sleep disruption, chronic stress, and thyroid dysfunction from the start, we set you up for sustainable change — not just a temporary loss.

Step 2: Personalized Treatment Plan and Dosing Protocol

If tirzepatide is right for you, I develop a customized dosing protocol that follows evidence-based guidelines:

• Treatment typically begins at 2.5 mg weekly for the first 4 weeks
• Dosage increases gradually in 2.5 mg increments based on your response, tolerability, and clinical goals
• The maintenance dose ranges from 5 mg to 15 mg weekly, individualized to your needs
• I adjust the timeline based on your side effect profile, weight loss trajectory, and metabolic markers

This careful titration is why physician oversight matters — dose increases that are too aggressive can cause unnecessary GI discomfort, while doses that are too conservative may limit results.

Step 3: Ongoing Support and Accountability

Regular check-ins, body composition tracking, lab monitoring, and open communication are the backbone of our program. I adjust your plan as your body responds, help you navigate side effects or plateaus, and celebrate milestones with you.

In my clinical experience, patients who have consistent access to their physician — combined with emotional support and accountability tools — achieve dramatically better long-term outcomes than those on medication alone. You don’t have to do this alone. Our GLP-1 medical weight loss program is designed around your unique journey.

Understanding Mounjaro Side Effects and Safety

As a physician, I believe in complete transparency about both benefits and risks. This is what responsible obesity medicine looks like.

Common Side Effects

The most frequently reported side effects of tirzepatide are gastrointestinal and typically occur during dose escalation:

• Nausea — most common, usually mild to moderate and often improves as your body adjusts
• Diarrhea
• Decreased appetite (which contributes to the weight loss effect)
• Constipation
• Vomiting
• Abdominal discomfort

In clinical trials, these side effects were mostly mild to moderate and tended to diminish over time. In my practice, I’ve found that careful dose titration and simple dietary adjustments significantly reduce GI symptoms for most patients.

Serious Side Effects (Rare but Important)

Contact your physician immediately if you experience:

• Severe abdominal pain that doesn’t go away (may indicate pancreatitis)
• Signs of an allergic reaction — rash, itching, swelling, difficulty breathing
• Symptoms of low blood sugar (particularly if taking insulin or sulfonylureas) — dizziness, sweating, confusion, rapid heartbeat
• Vision changes
• Signs of gallbladder problems — persistent upper abdominal pain, fever, jaundice

Thyroid Cancer Warning (Black Box)

Tirzepatide carries an FDA black box warning regarding the risk of thyroid C-cell tumors, observed in animal studies. While human relevance is uncertain, this medication should not be used in patients with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

This is precisely why a thorough medical evaluation before starting treatment is non-negotiable — and why I personally screen every patient at our Spring, TX clinic.

What Our Patients Say

Hearing directly from patients is one of the most meaningful parts of my work. Their experiences reinforce why a personalized, supportive approach matters:

“Started with the Semaglutide injections one week ago and so far so good. I can already tell the difference. The staff at Harmony Aesthetics are Wonderful, very knowledgeable and answered all questions. They make me feel very comfortable with what I’m doing.”

— Vicky, Harmony Aesthetics patient

You can read more patient reviews on Google here.

Weight Loss Clinics That Prescribe Mounjaro Near Me in Spring, TX and North Houston

Finding a physician-led Mounjaro weight loss clinic near you can make all the difference when you’re ready for real, lasting change. Our community across the Spring, TX and greater North Houston area is unique — busy families, demanding careers, Houston’s heat and social calendar, and the health challenges that come with midlife transitions all factor into a weight management plan that actually works.

At Harmony Aesthetics Spa, I offer in-person consultations and ongoing support across three convenient locations:

Spring, TX (Main Location)

3466 Discovery Creek Blvd, Ste 500, Spring, TX 77386
(346) 597-1202
Mon–Tue, Thu–Fri: 8am–5pm | Wed: 8am–5:30pm | Sat–Sun: Closed

Kingwood / Humble

1710 W. Lake Houston Pkwy, Ste 260B, Humble, TX 77339
(713) 590-7388
Mon–Thu: 8am–5pm | Fri–Sun: Closed

The Woodlands / Creekside (Luxe)

26940 Kuykendahl Rd, Ste 106, Tomball, TX 77375
(346) 597-2240 (you can text us)
Mon–Wed, Fri: 8am–5pm | Thu: 9am–6pm | Sat–Sun: Closed

Whether you’re in Spring, The Woodlands, Conroe, Kingwood, Humble, Tomball, or anywhere in the North Houston area, you have direct access to a board-certified physician who understands local lifestyle and health needs.

If you’re searching for weight loss clinics that prescribe Mounjaro near you in the Spring, TX area, I invite you to book your free consultation today. Text us to ask questions or schedule a visit — we’re here to help you achieve your goals, right in your community.

Conclusion

Weight loss clinics that prescribe Mounjaro offer a proven, physician-led pathway to real, lasting results — especially for patients who have felt dismissed, frustrated, or failed by generic programs. As a board-certified family physician and Fellow of the American Board of Obesity Medicine, I’ve seen firsthand how a comprehensive approach — rooted in the latest clinical evidence, personalized medical care, and genuine compassion — can transform lives.

The evidence is compelling: tirzepatide now has three-year sustained data showing 22.9% weight loss, head-to-head superiority over semaglutide, and confirmed cardiovascular safety. But what matters most is how those numbers translate into real confidence, energy, and quality of life for my patients.

If you’re in Spring, TX, The Woodlands, Kingwood, or anywhere in North Houston, you don’t have to navigate this alone. Book your free consultation today to start your personalized wellness journey. Text us at (346) 597-1202 to ask questions or schedule a visit — we’re here to help you take back control of your health and confidence with advanced medical care and ongoing support.

This article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment options.

Frequently Asked Questions

How do weight loss clinics that prescribe Mounjaro help patients achieve better results?

Physician-led clinics provide a comprehensive health evaluation, ongoing monitoring, and personalized dosing protocols that maximize both safety and effectiveness. At our clinic in Spring, TX, I combine tirzepatide therapy with lab-based metabolic screening, hormone evaluation, and lifestyle coaching. Clinical evidence shows that patients in physician-supervised programs consistently achieve greater weight loss and maintain it longer than those in unsupervised or online-only settings.

Where can I find a Mounjaro weight loss clinic near me in the Spring, TX area?

Harmony Aesthetics Spa offers physician-supervised Mounjaro and tirzepatide programs across three locations: Spring, TX (our flagship), Kingwood/Humble, and The Woodlands/Creekside. Each location provides in-person consultations with direct physician oversight. Contact us to schedule your free consultation.

What is the difference between Mounjaro and Zepbound?

Both Mounjaro and Zepbound contain the same active ingredient — tirzepatide — manufactured by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes management, while Zepbound is FDA-approved specifically for chronic weight management. Your physician will determine which prescription pathway is most appropriate based on your diagnosis, insurance coverage, and health goals.

How does Mounjaro compare to Ozempic for weight loss?

The SURMOUNT-5 trial (published in the New England Journal of Medicine, May 2025) directly compared tirzepatide to semaglutide in adults with obesity. Tirzepatide produced a 20.2% average weight loss, significantly outperforming semaglutide’s 13.7%. This advantage is attributed to tirzepatide’s dual GIP/GLP-1 mechanism, which targets two metabolic pathways rather than one.

What makes a physician-led weight loss program different for women in midlife?

A physician-led program addresses the unique hormonal and metabolic changes women face during perimenopause and menopause — factors like declining estrogen, thyroid dysfunction, insulin resistance, and cortisol imbalance. I evaluate these factors comprehensively and create a plan that supports both weight loss and overall hormonal balance, which generic programs simply cannot do. Learn more about our hormone replacement therapy options.

What are the side effects of Mounjaro (tirzepatide)?

The most common side effects include nausea, diarrhea, decreased appetite, constipation, and vomiting. These are typically mild to moderate and tend to improve as your body adjusts to the medication. Serious but rare side effects include pancreatitis and allergic reactions. Tirzepatide also carries an FDA black box warning regarding thyroid C-cell tumor risk. Thorough physician screening before and during treatment is essential for safe use.

How much weight can I lose on Mounjaro?

Results vary by individual, but clinical trials show average weight loss of 15–22.9% over 72 weeks, depending on dose. In the three-year SURMOUNT-1 extension, patients on the 15 mg dose sustained an average loss of 22.9%. In practice, I’ve seen many patients exceed these averages when tirzepatide is combined with individualized nutrition, exercise, and metabolic support.

Can I get Mounjaro without insurance?

Yes. While many insurance plans do cover tirzepatide (especially for diabetes indications), our team can help you navigate coverage options, manufacturer savings programs, and alternative pricing structures. We believe cost should not be a barrier to physician-led weight loss care. Contact us to discuss your specific situation.

How long do I need to take Mounjaro?

Obesity is a chronic condition, and current medical guidelines generally recommend ongoing treatment for sustained results. The three-year SURMOUNT-1 extension data demonstrates that continued tirzepatide use maintains weight loss over time. I work with each patient to develop a long-term plan that balances medication, lifestyle changes, and maintenance strategies tailored to their goals.

Do you offer other weight loss medications besides Mounjaro?

Yes. Our medical weight loss program includes multiple evidence-based options — semaglutide, tirzepatide, and other FDA-approved medications — so we can match the right treatment to your unique health profile. I never take a one-size-fits-all approach.

About the Author

Dr. Crystal Broussard, MD, is a board-certified family physician and Fellow of the American Board of Obesity Medicine. As the physician-owner and Medical Director of Harmony Aesthetics Spa in Spring, TX (with locations serving The Woodlands, Kingwood, and North Houston), Dr. Broussard combines over 20 years of clinical expertise with personal passion — having lost over 100 pounds herself following the birth of her first child. She specializes in physician-supervised medical weight loss, GLP-1 therapy, hormone optimization, and aesthetic medicine, helping patients achieve long-term wellness and confidence. A nationally recognized expert and featured contributor to programs like The PINK Method, Dr. Broussard is known for her warm, evidence-based approach and her commitment to empowering others through compassionate, physician-led care.

References

1. Jastreboff AM, Aronne LJ, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
2. Aronne LJ, Sattar N, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025. doi:10.1056/NEJMoa2416394
3. Nicholls SJ, Pavo I, Bhatt DL, et al. Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. N Engl J Med. 2025;393:2409-2420.
4. Eli Lilly and Company. Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks. Press Release, October 2024.
5. Wadden TA, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 randomized clinical trial. Nature Medicine. 2023.
6. Rodriguez PJ, Goodwin Cartwright BM, et al. Comparative Effectiveness of Tirzepatide vs Semaglutide. JAMA Intern Med. 2024. doi:10.1001/jamainternmed.2024.2525